RXDX
Wells Fargo’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,300
| Closed | -$1.96M | – | 7368 |
|
|
2023
Q1 | $1.96M | Buy |
18,300
+16,876
| +1,185% | +$1.81M | ﹤0.01% | 2703 |
|
|
2022
Q4 | $157K | Sell |
1,424
-5,605
| -80% | -$617K | ﹤0.01% | 4029 |
|
|
2022
Q3 | $414K | Buy |
7,029
+4,225
| +151% | +$249K | ﹤0.01% | 3572 |
|
|
2022
Q2 | $79K | Sell |
2,804
-5,800
| -67% | -$163K | ﹤0.01% | 4521 |
|
|
2022
Q1 | $325K | Sell |
8,604
-11,928
| -58% | -$451K | ﹤0.01% | 4418 |
|
|
2021
Q4 | $812K | Buy |
20,532
+5,086
| +33% | +$201K | ﹤0.01% | 4023 |
|
|
2021
Q3 | $367K | Buy |
15,446
+15,373
| +21,059% | +$365K | ﹤0.01% | 4572 |
|
|
2021
Q2 | $2K | Buy |
+73
| New | +$2K | ﹤0.01% | 6242 |
|